Global Prostate Cancer Diagnostics Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 116
Inquire Before Buying

The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.

Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.

North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.

The global Prostate Cancer Diagnostics market is valued at 11600 million US$ in 2020 is expected to reach 19100 million US$ by the end of 2026, growing at a CAGR of 7.3% during 2021-2026.

This report focuses on Prostate Cancer Diagnostics volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Prostate Cancer Diagnostics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Prostate Cancer Diagnostics market is segmented into

- Tumor Biomarker Tests

- Imaging

- Biopsy

- Other

Segment by Application

- age < 55

- age 55-75

- age > 75

Global Prostate Cancer Diagnostics Market: Regional Analysis

The Prostate Cancer Diagnostics market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Prostate Cancer Diagnostics market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Prostate Cancer Diagnostics Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Prostate Cancer Diagnostics market include:

- Genomic Health

- Abbott

- OPKO

- Siemens Healthcare

- DiaSorin

- BioMeriux

- Roche

- MDx Health

- Beckman Coulter

- Myriad Genetics

- Ambry Genetics

Global Prostate Cancer Diagnostics Market Research Report 2020

Table of Contents
1 Prostate Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnostics
1.2 Prostate Cancer Diagnostics Segment by Type
1.2.1 Global Prostate Cancer Diagnostics Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Prostate Cancer Diagnostics Segment by Application
1.3.1 Prostate Cancer Diagnostics Sales Comparison by Application: 2020 VS 2026
1.3.2 age < 55
1.3.3 age 55-75
1.3.4 age > 75
1.4 Global Prostate Cancer Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Diagnostics Revenue 2015-2026
1.4.2 Global Prostate Cancer Diagnostics Sales 2015-2026
1.4.3 Prostate Cancer Diagnostics Market Size by Region: 2020 Versus 2026
2 Global Prostate Cancer Diagnostics Market Competition by Manufacturers
2.1 Global Prostate Cancer Diagnostics Sales Market Share by Manufacturers (2015-2020)
2.2 Global Prostate Cancer Diagnostics Revenue Share by Manufacturers (2015-2020)
2.3 Global Prostate Cancer Diagnostics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Prostate Cancer Diagnostics Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Diagnostics Market Competitive Situation and Trends
2.5.1 Prostate Cancer Diagnostics Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Prostate Cancer Diagnostics Players (Opinion Leaders)
3 Prostate Cancer Diagnostics Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Diagnostics Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Prostate Cancer Diagnostics Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Prostate Cancer Diagnostics Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Diagnostics Sales by Country
3.3.2 North America Prostate Cancer Diagnostics Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Diagnostics Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Diagnostics Sales by Country
3.4.2 Europe Prostate Cancer Diagnostics Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Diagnostics Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Diagnostics Sales by Region
3.5.2 Asia Pacific Prostate Cancer Diagnostics Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prostate Cancer Diagnostics Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Diagnostics Sales by Country
3.6.2 Latin America Prostate Cancer Diagnostics Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Prostate Cancer Diagnostics Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Diagnostics Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prostate Cancer Diagnostics Historic Market Analysis by Type
4.1 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
4.2 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2020)
4.3 Global Prostate Cancer Diagnostics Price Market Share by Type (2015-2020)
4.4 Global Prostate Cancer Diagnostics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Prostate Cancer Diagnostics Historic Market Analysis by Application
5.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
5.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020)
5.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020)
6 Company Profiles and Key Figures in Prostate Cancer Diagnostics Business
6.1 Genomic Health
6.1.1 Corporation Information
6.1.2 Genomic Health Description, Business Overview and Total Revenue
6.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Genomic Health Products Offered
6.1.5 Genomic Health Recent Development
6.2 Abbott
6.2.1 Abbott Prostate Cancer Diagnostics Production Sites and Area Served
6.2.2 Abbott Description, Business Overview and Total Revenue
6.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Abbott Products Offered
6.2.5 Abbott Recent Development
6.3 OPKO
6.3.1 OPKO Prostate Cancer Diagnostics Production Sites and Area Served
6.3.2 OPKO Description, Business Overview and Total Revenue
6.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.3.4 OPKO Products Offered
6.3.5 OPKO Recent Development
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Prostate Cancer Diagnostics Production Sites and Area Served
6.4.2 Siemens Healthcare Description, Business Overview and Total Revenue
6.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Siemens Healthcare Products Offered
6.4.5 Siemens Healthcare Recent Development
6.5 DiaSorin
6.5.1 DiaSorin Prostate Cancer Diagnostics Production Sites and Area Served
6.5.2 DiaSorin Description, Business Overview and Total Revenue
6.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.5.4 DiaSorin Products Offered
6.5.5 DiaSorin Recent Development
6.6 BioMeriux
6.6.1 BioMeriux Prostate Cancer Diagnostics Production Sites and Area Served
6.6.2 BioMeriux Description, Business Overview and Total Revenue
6.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BioMeriux Products Offered
6.6.5 BioMeriux Recent Development
6.7 Roche
6.6.1 Roche Prostate Cancer Diagnostics Production Sites and Area Served
6.6.2 Roche Description, Business Overview and Total Revenue
6.6.3 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Roche Products Offered
6.7.5 Roche Recent Development
6.8 MDx Health
6.8.1 MDx Health Prostate Cancer Diagnostics Production Sites and Area Served
6.8.2 MDx Health Description, Business Overview and Total Revenue
6.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.8.4 MDx Health Products Offered
6.8.5 MDx Health Recent Development
6.9 Beckman Coulter
6.9.1 Beckman Coulter Prostate Cancer Diagnostics Production Sites and Area Served
6.9.2 Beckman Coulter Description, Business Overview and Total Revenue
6.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Beckman Coulter Products Offered
6.9.5 Beckman Coulter Recent Development
6.10 Myriad Genetics
6.10.1 Myriad Genetics Prostate Cancer Diagnostics Production Sites and Area Served
6.10.2 Myriad Genetics Description, Business Overview and Total Revenue
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Myriad Genetics Products Offered
6.10.5 Myriad Genetics Recent Development
6.11 Ambry Genetics
6.11.1 Ambry Genetics Prostate Cancer Diagnostics Production Sites and Area Served
6.11.2 Ambry Genetics Prostate Cancer Diagnostics Description, Business Overview and Total Revenue
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Ambry Genetics Products Offered
6.11.5 Ambry Genetics Recent Development
7 Prostate Cancer Diagnostics Manufacturing Cost Analysis
7.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
7.4 Prostate Cancer Diagnostics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Diagnostics Distributors List
8.3 Prostate Cancer Diagnostics Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Prostate Cancer Diagnostics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Prostate Cancer Diagnostics by Type (2021-2026)
10.2 Prostate Cancer Diagnostics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Prostate Cancer Diagnostics by Application (2021-2026)
10.3 Prostate Cancer Diagnostics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Prostate Cancer Diagnostics by Region (2021-2026)
10.4 North America Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.5 Europe Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.6 Asia Pacific Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.7 Latin America Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.8 Middle East and Africa Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Prostate Cancer Diagnostics Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Prostate Cancer Diagnostics Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Prostate Cancer Diagnostics Manufacturers Covered in This Study
Table 5. Global Prostate Cancer Diagnostics Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Prostate Cancer Diagnostics Sales Share by Manufacturers (2015-2020)
Table 7. Global Prostate Cancer Diagnostics Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Prostate Cancer Diagnostics Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Prostate Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Prostate Cancer Diagnostics Sales Sites and Area Served
Table 11. Manufacturers Prostate Cancer Diagnostics Product Types
Table 12. Global Prostate Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Prostate Cancer Diagnostics Players
Table 16. Global Prostate Cancer Diagnostics Sales (K Units) by Region (2015-2020)
Table 17. Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Table 18. Global Prostate Cancer Diagnostics Revenue (Million US$) by Region (2015-2020)
Table 19. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
Table 20. North America Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 21. North America Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 22. North America Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 24. Europe Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 25. Europe Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 26. Europe Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Prostate Cancer Diagnostics Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Prostate Cancer Diagnostics Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
Table 32. Latin America Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 33. Latin America Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 34. Latin America Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 40. Global Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 41. Global Prostate Cancer Diagnostics Sales Share by Type (2015-2020)
Table 42. Global Prostate Cancer Diagnostics Revenue (Million US$) by Type (2015-2020)
Table 43. Global Prostate Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 44. Global Prostate Cancer Diagnostics Price (USD/Unit) by Type (2015-2020)
Table 45. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 46. Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 47. Global Prostate Cancer Diagnostics Sales Growth Rate by Application (2015-2020)
Table 48. Genomic Health Prostate Cancer Diagnostics Corporation Information
Table 49. Genomic Health Description and Business Overview
Table 50. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Genomic Health Main Product
Table 52. Genomic Health Recent Development
Table 53. Abbott Prostate Cancer Diagnostics Corporation Information
Table 54. Abbott Corporation Information
Table 55. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Abbott Main Product
Table 57. Abbott Recent Development
Table 58. OPKO Prostate Cancer Diagnostics Corporation Information
Table 59. OPKO Corporation Information
Table 60. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. OPKO Main Product
Table 62. OPKO Recent Development
Table 63. Siemens Healthcare Prostate Cancer Diagnostics Corporation Information
Table 64. Siemens Healthcare Corporation Information
Table 65. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Siemens Healthcare Main Product
Table 67. Siemens Healthcare Recent Development
Table 68. DiaSorin Prostate Cancer Diagnostics Corporation Information
Table 69. DiaSorin Corporation Information
Table 70. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. DiaSorin Main Product
Table 72. DiaSorin Recent Development
Table 73. BioMeriux Prostate Cancer Diagnostics Corporation Information
Table 74. BioMeriux Corporation Information
Table 75. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. BioMeriux Main Product
Table 77. BioMeriux Recent Development
Table 78. Roche Prostate Cancer Diagnostics Corporation Information
Table 79. Roche Corporation Information
Table 80. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Roche Main Product
Table 82. Roche Recent Development
Table 83. MDx Health Prostate Cancer Diagnostics Corporation Information
Table 84. MDx Health Corporation Information
Table 85. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. MDx Health Main Product
Table 87. MDx Health Recent Development
Table 88. Beckman Coulter Prostate Cancer Diagnostics Corporation Information
Table 89. Beckman Coulter Corporation Information
Table 90. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Beckman Coulter Main Product
Table 92. Beckman Coulter Recent Development
Table 93. Myriad Genetics Prostate Cancer Diagnostics Corporation Information
Table 94. Myriad Genetics Corporation Information
Table 95. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Myriad Genetics Main Product
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Prostate Cancer Diagnostics Corporation Information
Table 99. Ambry Genetics Corporation Information
Table 100. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Ambry Genetics Main Product
Table 102. Ambry Genetics Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Prostate Cancer Diagnostics Distributors List
Table 106. Prostate Cancer Diagnostics Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Prostate Cancer Diagnostics Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Prostate Cancer Diagnostics Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Prostate Cancer Diagnostics Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Prostate Cancer Diagnostics
Figure 2. Global Prostate Cancer Diagnostics Sales Market Share by Type: 2020 VS 2026
Figure 3. Tumor Biomarker Tests Product Picture
Figure 4. Imaging Product Picture
Figure 5. Biopsy Product Picture
Figure 6. Other Product Picture
Figure 7. Global Prostate Cancer Diagnostics Consumption Market Share by Application: 2020 VS 2026
Figure 8. age < 55
Figure 9. age 55-75
Figure 10. age > 75
Figure 11. Global Prostate Cancer Diagnostics Market Size 2015-2026 (US$ Million)
Figure 12. Global Prostate Cancer Diagnostics Sales Capacity (K Units) (2015-2026)
Figure 13. Global Prostate Cancer Diagnostics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Prostate Cancer Diagnostics Sales Share by Manufacturers in 2020
Figure 15. Global Prostate Cancer Diagnostics Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Prostate Cancer Diagnostics Revenue in 2019
Figure 17. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Figure 19. Global Prostate Cancer Diagnostics Sales Market Share by Region in 2019
Figure 20. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
Figure 21. Global Prostate Cancer Diagnostics Revenue Market Share by Region in 2019
Figure 22. North America Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 23. North America Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 24. U.S. Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 29. Europe Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 30. Germany Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Prostate Cancer Diagnostics Sales Market Share by Region in 2019
Figure 41. Asia Pacific Prostate Cancer Diagnostics Revenue Market Share by Region in 2019
Figure 42. China Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 65. Latin America Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 66. Mexico Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 74. Turkey Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Prostate Cancer Diagnostics by Type (2015-2020)
Figure 81. Sales Market Share of Prostate Cancer Diagnostics by Type in 2019
Figure 82. Revenue Share of Prostate Cancer Diagnostics by Type (2015-2020)
Figure 83. Revenue Market Share of Prostate Cancer Diagnostics by Type in 2019
Figure 84. Global Prostate Cancer Diagnostics Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 86. Global Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Prostate Cancer Diagnostics by Application (2015-2020)
Figure 88. Global Revenue Share of Prostate Cancer Diagnostics by Application in 2020
Figure 89. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. OPKO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. BioMeriux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. MDx Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Ambry Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure 102. Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure 103. Prostate Cancer Diagnostics Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. North America Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed
  • Global Prostate Cancer Diagnostics Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 116
    The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests,......
  • Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2020
    Published: 01-Jan-2020        Price: US 2900 Onwards        Pages: 99
    Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1......
  • Global PSA Test Market Research Report 2020
    Published: 01-Jan-2020        Price: US 2900 Onwards        Pages: 124
    Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood. The global average price of PSA Test is in the decreasing trend, from 617 USD/Unit in 2011 to 595 USD/ Unit in 2016. ......
  • Global Cancer Diagnostics Market Professional Survey 2019 by Manufacturers, Regions, Types and Applications, Forecast to 2024
    Published: 31-Dec-2019        Price: US 2600 Onwards        Pages: 185
    In this report, we analyze the Cancer Diagnostics industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make a......
  • 2017-2025 World HPV Testing Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 25-Dec-2019        Price: US 2800 Onwards        Pages: 110
    Summary The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing. This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and ......
  • 2017-2025 World Prostate Cancer Diagnostics Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 25-Dec-2019        Price: US 2800 Onwards        Pages: 116
    Summary The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biop......
  • 2017-2025 World PSA Test Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 24-Dec-2019        Price: US 2800 Onwards        Pages: 104
    Summary Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood This report includes market status and forecast of global and major regions, with introduction of ven......
  • Cancer/Tumor Profiling Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Dec-2019        Price: US 3000 Onwards        Pages: 143
    Cancer/Tumor Profiling Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cancer/Tumor Profiling industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cancer/Tumor Profiling manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chine......
  • 2017-2025 World Checkpoint Inhibitors for Treating Cancer Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 19-Dec-2019        Price: US 2800 Onwards        Pages: 109
    Summary Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the "brakes" on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs